Physician
Best Care Pediatrics LLC
Best Care Pediatrics LLC was paid $2.37M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoBEST CARE PEDIATRICS LLC
MILWAUKEE, WI 53221
MILWAUKEE, WI 53221
33aNPI1811333867assigned 05/17/2013
33bProvider typePediatrics Physician
28Total paid$2.37M
24GClaims85,792
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Wisconsin
Rank by total paid#6 of 200
Median peer was paid$4K
This provider vs. median543×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,762 | $423K | |
| 2019 | 18,050 | $401K | |
| 2020 | 11,760 | $307K | |
| 2021 | 11,493 | $360K | |
| 2022 | 11,276 | $421K | |
| 2023 | 8,340 | $264K | |
| 2024incomplete | 5,111 | $192K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 12,995 | 11,056 | $802K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 5,738 | 4,783 | $242K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.7% | 2,776 | 2,599 | $158K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 2,704 | 2,547 | $157K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5.3% | 4,715 | 4,441 | $125K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.9% | 2,112 | 1,959 | $117K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.7% | 3,261 | 2,908 | $110K |
| 99173 | 4.1% | 5,390 | 5,006 | $96K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.7% | 2,118 | 1,921 | $88K |
| D1208 | Topical application of fluoride, excluding varnish | 3.1% | 5,714 | 5,386 | $73K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.7% | 1,115 | 1,060 | $65K |
| 92551 | 2.7% | 5,320 | 4,935 | $65K |
46 more codes
| 3008F | 2.6% | 7,224 | $62K | |
| 99215 | Doctor's office visit, returning patient (complex) | 2.1% | 646 | $50K |
| 80061 | Lipid panel | 1.1% | 1,751 | $25K |
| 99205 | Prolong outpt/office vis | <1% | 131 | $23K |
| 83655 | <1% | 1,680 | $22K | |
| 90658 | <1% | 3,585 | $20K | |
| 85018 | <1% | 3,816 | $10K | |
| 36416 | <1% | 3,590 | $10K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 65 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 222 | $6K |
| 90670 | <1% | 1,183 | $5K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 184 | $3K |
| 96127 | <1% | 840 | $3K | |
| 90657 | <1% | 667 | $3K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 28 | $3K |
| 90680 | <1% | 598 | $2K | |
| 90723 | <1% | 564 | $2K | |
| 90648 | <1% | 578 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 33 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 99 | $2K |
| 90633 | <1% | 343 | $1K | |
| 90651 | <1% | 177 | $1K | |
| 86580 | <1% | 165 | $996.04 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 51 | $992.72 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $671.98 |
| 94010 | <1% | 12 | $350.02 | |
| 81002 | <1% | 111 | $321.33 | |
| 80305 | <1% | 38 | $313.80 | |
| 99442 | <1% | 16 | $266.58 | |
| 90734 | <1% | 57 | $253.10 | |
| 90697 | <1% | 28 | $212.83 | |
| 90619 | <1% | 13 | $204.00 | |
| 90671 | <1% | 13 | $169.50 | |
| 95117 | <1% | 22 | $117.65 | |
| 90698 | <1% | 23 | $96.46 | |
| 90620 | <1% | 27 | $73.31 | |
| 90696 | <1% | 15 | $63.31 | |
| 90649 | <1% | 13 | $56.62 | |
| 90700 | <1% | 15 | $48.17 | |
| 90710 | <1% | 15 | $45.43 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 24 | $0.36 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 72 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 995 | $0.00 |
| 90461 | 0% | 90 | $0.00 | |
| 90473 | 0% | 23 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 1,974 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARCE-GARZON, SANDRA (OWNER)